Complaints of poor nocturnal sleep and daytime dysfunction may be frequent among women receiving chemotherapy for breast cancer. A critical review of the literature was conducted, which aimed at summarising and critically analysing findings regarding sleep in women with early-stage breast cancer across neo-/adjuvant chemotherapy treatment. A systematic search of three electronic databases (Medline, CINAHL, EMBASE) was conducted from January 1980 to July 2011. Twenty-one articles reporting on 12 studies were included for analysis based on pre-specified selection criteria. Varying deficits in sleep parameters may be evident in a significant part of this population. Yet, research data are not equally distributed among the different sleep compo...
This study examined the longitudinal relation between health-related quality of life (HR-QOL) and su...
Background: Sleep is increasingly recognized as an area of functioning that may be greatly affected ...
[[abstract]]Within the top-ten cancers, the gross incidence rate of the cervical cancer and uterine ...
Complaints of poor nocturnal sleep and daytime dysfunction may be frequent among women receiving che...
Complaints of poor nocturnal sleep and daytime dysfunction may be frequent among women receiving che...
Purpose/Objectives: To conduct a metasynthesis of human sleep studies that included women aged 50 ye...
Sleep disruption is prevalent in patients and survivors of breast cancer. Most patients undergoing c...
Insomnia causes severe distress in patients with breast cancer who receive chemotherapy. Few studies...
BACKGROUND: Insomnia causes severe distress in patients with breast cancer who receive chemotherapy....
Rationale. Secondary to breast cancer and its treatment, fatigue has been identified as one of the m...
Context: Data regarding health-related quality of life in breast cancer patients in the Middle East ...
PurposeSleep disturbance and cancer-related fatigue (CRF) are among the most commonly reported sympt...
Sleep disturbances are highly prevalent in women with breast cancer; side effects of cancer treatmen...
Goals of workThe goal of this study was to examine the relationship between menopausal symptoms, sle...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73246/1/j.1524-4741.2002.08606.x.pd
This study examined the longitudinal relation between health-related quality of life (HR-QOL) and su...
Background: Sleep is increasingly recognized as an area of functioning that may be greatly affected ...
[[abstract]]Within the top-ten cancers, the gross incidence rate of the cervical cancer and uterine ...
Complaints of poor nocturnal sleep and daytime dysfunction may be frequent among women receiving che...
Complaints of poor nocturnal sleep and daytime dysfunction may be frequent among women receiving che...
Purpose/Objectives: To conduct a metasynthesis of human sleep studies that included women aged 50 ye...
Sleep disruption is prevalent in patients and survivors of breast cancer. Most patients undergoing c...
Insomnia causes severe distress in patients with breast cancer who receive chemotherapy. Few studies...
BACKGROUND: Insomnia causes severe distress in patients with breast cancer who receive chemotherapy....
Rationale. Secondary to breast cancer and its treatment, fatigue has been identified as one of the m...
Context: Data regarding health-related quality of life in breast cancer patients in the Middle East ...
PurposeSleep disturbance and cancer-related fatigue (CRF) are among the most commonly reported sympt...
Sleep disturbances are highly prevalent in women with breast cancer; side effects of cancer treatmen...
Goals of workThe goal of this study was to examine the relationship between menopausal symptoms, sle...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73246/1/j.1524-4741.2002.08606.x.pd
This study examined the longitudinal relation between health-related quality of life (HR-QOL) and su...
Background: Sleep is increasingly recognized as an area of functioning that may be greatly affected ...
[[abstract]]Within the top-ten cancers, the gross incidence rate of the cervical cancer and uterine ...